Ishita Drugs & Industries has informed that pursuant to the requirement of Regulation 7(2) & 7(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the Company enclosed Compliance Certificate for the half year ended on 31st March, 2021.
The above information is a part of company’s filings submitted to BSE.